Details for New Drug Application (NDA): 210011
✉ Email this page to a colleague
The generic ingredient in ALBENDAZOLE is albendazole. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the albendazole profile page.
Summary for 210011
Tradename: | ALBENDAZOLE |
Applicant: | Strides Pharma |
Ingredient: | albendazole |
Patents: | 0 |
Pharmacology for NDA: 210011
Mechanism of Action | Cytochrome P450 1A Inducers |
Medical Subject Heading (MeSH) Categories for 210011
Suppliers and Packaging for NDA: 210011
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALBENDAZOLE | albendazole | TABLET;ORAL | 210011 | ANDA | Camber Pharmaceuticals | 31722-935 | 31722-935-02 | 2 TABLET, FILM COATED in 1 BOTTLE (31722-935-02) |
ALBENDAZOLE | albendazole | TABLET;ORAL | 210011 | ANDA | Camber Pharmaceuticals | 31722-935 | 31722-935-28 | 28 TABLET, FILM COATED in 1 BOTTLE (31722-935-28) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | Dec 7, 2018 | TE: | RLD: | No |
Complete Access Available with Subscription